Binge Eating Disorder (BED) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032


 

Binge Eating Disorder (BED) is defined as an eating disorder marked by repetitive instances of binge eating, during which the person consumes more food than would typically be consumed within a distinct timeframe. Binge eating disorder (BED) is closely related to non-purging bulimia nervosa (BN), although there are distinctions between the two. The key characteristics of BED involve engaging in episodes of binge eating, occurring at least twice a week for six months, and accompanied by considerable distress. Unlike nonpurging bulimia nervosa, BED does not involve compensatory actions to avoid weight gain, such as self-induced vomiting, laxative or diuretic use, or other medications. While many individuals with BED are overweight, not all fall into this category. Overweight individuals with BED are subject to the typical health risks of obesity, such as diabetes, hypertension, and orthopedic issues. The binge-eating disorder commonly emerges as an outcome or consequence of depression. Individuals often resort to "comfort foods" to cope with their depressive feelings. The development of binge-eating disorder, similar to anorexia nervosa or bulimia nervosa, may initiate from low self-esteem or self-image. This disorder tends to arise when attempts to enhance self-assurance prove unsuccessful or go unrecognized externally. Faulty internal communication can also contribute to the development of binge-eating disorder. Factors that contribute to the emergence of this disorder include severe childhood obesity, a family history of overeating, experiences of body-related bullying or teasing, and substance abuse such as drugs or alcohol. Binge-eating disorder is most frequently identified in individuals who are overweight or obese. Current diagnostic criteria necessitate the occurrence of at least one binge episode per week for a duration of three months. Individuals grappling with binge-eating disorder are at an elevated risk of encountering depression and substance misuse. The treatment of binge-eating disorder in adults has succeeded through a combination of cognitive-behavioral therapy and antidepressant medication.

 

BED is the most prevalent eating disorder in both the United States and Europe, with higher occurrences observed among teenagers and young adults. On average, the onset of BED occurs around the age of 25.

·       The prevalence of BED in children globally stands at 0.7%. In males, the one-year prevalence of BED is 0.26%, with the highest prevalence (0.48%) occurring in males aged 10-19. Among women, the age group of 20-29 exhibits the highest BED prevalence rates, estimated at 2.09%.

Thelansis’s “Binge Eating Disorder (BED) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Binge Eating Disorder (BED) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Binge Eating Disorder (BED) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Binge Eating Disorder (BED) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Binge Eating Disorder (BED) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Herpes Simplex Virus (HSV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Herpes simplex virus (HSV) causes an infection that affects the external genitalia, anal region, mucosal surfaces, and skin in other body parts. Herpes simplex virus is a ubiquitous, host-adapted pathogen that causes various disease states. There are two types of HSV with two distinct DNA viruses, type 1 (HSV-1) and type 2 (HSV-2). Both the types are closely related but differ epidemiologically. HSV-1 is traditionally associated with orofacial disease by affecting the mouth and lips with fever blisters and cold sores, whereas HSV-2 is associated traditionally with genital disease infecting genitals and rectum area with sores and is classified as STD (sexually transmitted disease). As HSV-1 is associated with genital infections more often than HSV-2, lesion location is not necessarily of viral type. HSV can spread through direct contact. Almost 80% of Herpes simplex infections are asymptomatic, while symptomatic infections can be characterized by significant morbidity and recurrenc...
Read more

HR+/HER2- Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
Thelansis’s “HR+/HER2- Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HR+/HER2- Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of HR+/HER2- Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. HR+/HER2- Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model,...
Read more